In the last trading session, 0.15 million shares of the Aadi Bioscience Inc (NASDAQ:AADI) were traded, and its beta was 0.65. Most recently the company’s share price was $2.98, and it changed around -$0.15 or -4.79% from the last close, which brings the market valuation of the company to $73.55M. AADI currently trades at a discount to its 52-week high of $3.81, offering almost -27.85% off that amount. The share price’s 52-week low was $1.21, which indicates that the current value has risen by an impressive 59.4% since then. We note from Aadi Bioscience Inc’s average daily trading volume that its 10-day average is 0.36 million shares, with the 3-month average coming to 353.23K.
Aadi Bioscience Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 3 recommended AADI as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Aadi Bioscience Inc (NASDAQ:AADI) trade information
Instantly AADI has showed a red trend with a performance of -4.79% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 3.59 on recent trading dayincreased the stock’s daily price by 16.99%. The company’s shares are currently down -5.55% year-to-date, but still down -17.22% over the last five days. On the other hand, Aadi Bioscience Inc (NASDAQ:AADI) is 25.21% up in the 30-day period. We can see from the shorts that 0.55 million shares have been sold at a short interest cover period of 0.78 day(s).
The consensus price target as assigned by Wall Street analysts is $1.62, which translates to bulls needing to decrease their stock price by -83.95% from its current value. Analyst projections state that AADI is forecast to be at a low of $1.5 and a high of $1.75.
Aadi Bioscience Inc (AADI) estimates and forecasts
Aadi Bioscience Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 94.77 percent over the past six months and at a 16.39% annual growth rate that is well below the industry average of 16.50%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 11.87%.
AADI Dividends
Aadi Bioscience Inc’s next quarterly earnings report is expected to be released in February.
Aadi Bioscience Inc (NASDAQ:AADI)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 11.31% of Aadi Bioscience Inc shares, and 51.88% of them are in the hands of institutional investors. The stock currently has a share float of 58.49%. Aadi Bioscience Inc stock is held by 63.0 institutions, with AVORO CAPITAL ADVISORS LLC being the largest institutional investor. By 2024-06-30, it held 10.5494% of the shares, which is about 2.85 million shares worth $4.16 million.
ACUTA CAPITAL PARTNERS, LLC, with 6.8471% or 1.85 million shares worth $2.7 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
